OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
228
Results
Show all
Save search
Copy query
Show results for
Unknown
(226)
Metabolomics
(1)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
MetaboLights
(1)
pride
(1)
Tissue
Brain
(1)
Cell culture
(1)
Disease
Diffuse midline glioma
(1)
Technology Type
Mass spectrometry
(1)
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Instrument Platform
Gas Chromatography MS - positive
(1)
Liquid Chromatography MS - negative - reverse phase
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
Publication Date
2023
(2)
CHEBI ID
CHEBI:10033
(1)
CHEBI:10334
(1)
CHEBI:104022
(1)
CHEBI:10587
(1)
CHEBI:107636
(1)
CHEBI:110187
(1)
CHEBI:112
(1)
CHEBI:1148
(1)
CHEBI:116314
(1)
CHEBI:1230
(1)
CHEBI:131381
(1)
CHEBI:131421
(1)
CHEBI:131454
(1)
CHEBI:131659
(1)
CHEBI:131668
(1)
CHEBI:131738
(1)
CHEBI:131888
(1)
CHEBI:131989
(1)
CHEBI:132274
(1)
CHEBI:132996
(1)
CHEBI:133077
(1)
CHEBI:133094
(1)
CHEBI:133096
(1)
CHEBI:133140
(1)
CHEBI:133144
(1)
CHEBI:133657
(1)
CHEBI:134013
(1)
CHEBI:134014
(1)
CHEBI:134021
(1)
CHEBI:134254
(1)
Metabolite Name
(-)-12-hydroxy-9,10-dihydrojasmonic acid
(1)
(-)-2,7-Dolabelladiene-6beta,10alpha,18-triol
(1)
(-)-8-hydroxy-11E,17-octadecadien-9-ynoic acid
(1)
(-)-Cladielline
(1)
(-)-Dilophol
(1)
(-)-erythro-Anethole glycol 1-glucoside
(1)
(-)-erythro-Anethole glycol 2-glucoside
(1)
(1R,2R)-3-oxo-2-pentyl-cyclopentanehexanoic acid
(1)
(1R,2R,4S)-p-Menthane-1,2,8-triol 8-glucoside
(1)
(1S,2S)-3-oxo-2-pentyl-cyclopentanehexanoic acid
(1)
(22E)-3beta-Hydroxy-5alpha-chola-7,22-dien-24-oic Acid
(1)
(2E,4Z)-Decadienoylcarnitine
(1)
(2R*,3R*)-1,2,3-Butanetriol
(1)
(2R,3R,4R)-2-Amino-4-hydroxy-3-methylpentanoic acid
(1)
(2S,4S)-Monatin
(1)
(3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one
(1)
(3b,6b,8b,12a)-8,12-Epoxy-7(11)-eremophilene-6-angeloyloxy-8,12-dimethoxy-3-ol
(1)
(4E,15E)-Bilirubin
(1)
(4E,8E,10E-d18:3)sphingosine
(1)
(5alpha,8beta,9beta)-5,9-Epoxy-3,6-megastigmadien-8-ol
(1)
(6E,8E,10R,12Z)-10-Hydroxy-3-oxooctadecatrienoic acid
(1)
(6E,9E,12E,15E,18E,21E)-tetracosa-6,9,12,15,18,21-hexaenoic acid
(1)
(6beta,8alpha)-6-Hydroxy-7(11)-eremophilen-12,8-olide
(1)
(7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid
(1)
(9R,10S,12Z)-9,10-Dihydroxy-8-oxo-12-octadecenoic acid
(1)
(9R,13R)-1a,1b-dinor-10,11-dihydro-12-oxo-15-phytoenoic acid
(1)
(9S,13S)-1a,1b-dihomo-jasmonic acid
(1)
(9Z,11R,12S,13S,15Z)-12,13-Epoxy-11-hydroxy-9,15-octadecadienoic acid
(1)
(E)-2-Methyl-2-buten-1-ol O-beta-D-Glucopyranoside
(1)
(Z)-10-Hydroxy-8-decene-4,6-diynoic acid
(1)
Release Date
2022
(36)
2021
(30)
2024
(26)
2023
(22)
2025
(16)
2020
(14)
2018
(12)
2015
(10)
2016
(9)
2011
(9)
2019
(8)
2014
(8)
2017
(7)
2012
(6)
2010
(5)
2026
(4)
2009
(2)
2008
(2)
Lab affiliation
1. Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, AUSTRALIA 2. Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, AUSTRALIA 3. Paediatric Program, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, NSW, AUSTRALIA
(1)
Previous
page
1 / 23
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
23
Next
page
Sort
by:
Relevance
Page size
10
The CFIR Card Game: a new approach for working with implementation teams to identify challenges and strategies.
Not available
S-EPMC7791817
|
biostudies-literature
Cite
De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental Disorder.
Not available
S-EPMC5294671
|
biostudies-literature
Cite
De novo HNF4A-associated atypical Fanconi renal tubulopathy syndrome.
Not available
S-EPMC10920409
|
biostudies-literature
Cite
Identifying and understanding the contextual factors that shaped mid-implementation outcomes during the COVID-19 pandemic in organizations implementing mental health recovery innovations into services.
Not available
S-EPMC8441235
|
biostudies-literature
Cite
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.
Not available
S-EPMC4383838
|
biostudies-literature
Cite
Prevalence and architecture of de novo mutations in developmental disorders.
Not available
S-EPMC6016744
|
biostudies-literature
Cite
Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol.
Not available
S-EPMC7322334
|
biostudies-literature
Cite
An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.
Not available
S-EPMC8026396
|
biostudies-literature
Cite
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
Not available
S-EPMC3149738
|
biostudies-literature
Cite
Mutations in CEP57 cause mosaic variegated aneuploidy syndrome.
Not available
S-EPMC3508359
|
biostudies-literature
Cite
Previous
page
1 / 23
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
23
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
